Viatris, Inc. recalls

2 recalls.

• Telmisartan and Amlodipine recall (Viatris, Inc.)
  DrugClass IIIReported October 28, 2026 · Superpotent Drug: potential for the Telmisartan content in these lots to exceed specifications
• Xanax XR recall (Viatris, Inc.)
  DrugClass IIReported April 15, 2026 · Failed Dissolution Specifications